Variant report
Variant | nsv965693 |
---|---|
Chromosome Location | chr6:26844272-26847191 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:21)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:21 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr6:26846401-26846598 | GM12878 | blood: | n/a | n/a |
2 | BCL11A | chr6:26846337-26846537 | GM12878 | blood: | n/a | n/a |
3 | FOSL2 | chr6:26846318-26846630 | HepG2 | liver: | n/a | n/a |
4 | GABPA | chr6:26846377-26846501 | Hela-S3 | cervix: | n/a | n/a |
5 | GABPA | chr6:26845250-26845486 | Hela-S3 | cervix: | n/a | n/a |
6 | GABPA | chr6:26846367-26846597 | Hela-S3 | cervix: | n/a | n/a |
7 | GATA2 | chr6:26844498-26844738 | K562 | blood: | n/a | n/a |
8 | IRF4 | chr6:26847172-26847598 | GM12878 | blood: | n/a | n/a |
9 | IRF4 | chr6:26846304-26846683 | GM12878 | blood: | n/a | n/a |
10 | PAX5 | chr6:26846344-26846616 | GM12878 | blood: | n/a | n/a |
11 | PAX5 | chr6:26847180-26847509 | GM12878 | blood: | n/a | n/a |
12 | PAX5 | chr6:26847157-26847636 | GM12878 | blood: | n/a | n/a |
13 | POLR2A | chr6:26846308-26846573 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr6:26846226-26846863 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | POU2F2 | chr6:26846474-26846638 | GM12878 | blood: | n/a | n/a |
16 | RXRA | chr6:26846252-26846807 | HepG2 | liver: | n/a | n/a |
17 | SIX5 | chr6:26846332-26846625 | K562 | blood: | n/a | n/a |
18 | SIX5 | chr6:26845974-26846210 | K562 | blood: | n/a | n/a |
19 | SIX5 | chr6:26846313-26846582 | K562 | blood: | n/a | n/a |
20 | ZBTB33 | chr6:26846365-26846645 | K562 | blood: | n/a | n/a |
21 | ZBTB33 | chr6:26847172-26847502 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GUSBP2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531844880 | chr6:26844289-26844290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548517926 | chr6:26844491-26844492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568305634 | chr6:26844591-26844592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs62400801 | chr6:26844660-26844661 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs185294944 | chr6:26844749-26844750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112909884 | chr6:26844829-26844830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145575410 | chr6:26844850-26844851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs3933235 | chr6:26844942-26844943 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs556478301 | chr6:26844972-26844973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576506451 | chr6:26844995-26844996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544517928 | chr6:26845005-26845006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9461305 | chr6:26845015-26845016 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs376727160 | chr6:26845016-26845017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574671108 | chr6:26845017-26845018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs3933236 | chr6:26845033-26845034 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs548289929 | chr6:26845036-26845037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556581073 | chr6:26845041-26845042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560112569 | chr6:26845050-26845051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532198008 | chr6:26845084-26845085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545590193 | chr6:26845122-26845123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201040596 | chr6:26845198-26845199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190004859 | chr6:26845224-26845225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371362843 | chr6:26845247-26845248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548455872 | chr6:26845251-26845252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568442313 | chr6:26845279-26845280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2475089 | chr6:26845280-26845281 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs547935390 | chr6:26845282-26845283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570962448 | chr6:26845525-26845526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539872115 | chr6:26845540-26845541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556744543 | chr6:26845585-26845586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs373733450 | chr6:26845589-26845590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375911892 | chr6:26845756-26845757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570059638 | chr6:26845771-26845772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs62400802 | chr6:26845795-26845796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs62400803 | chr6:26845801-26845802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs202207599 | chr6:26845826-26845827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369148061 | chr6:26845857-26845858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372890368 | chr6:26845862-26845863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375210715 | chr6:26845863-26845864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201772917 | chr6:26845867-26845868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9467925 | chr6:26845922-26845923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553892131 | chr6:26845973-26845974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370411901 | chr6:26846019-26846020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576969309 | chr6:26846094-26846095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545873657 | chr6:26846143-26846144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141107116 | chr6:26846155-26846156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs62400804 | chr6:26846161-26846162 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
48 | rs541396233 | chr6:26846194-26846195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561359719 | chr6:26846242-26846243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138932917 | chr6:26846275-26846276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21509527 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26834600-26848800 | Weak transcription | Liver | Liver |
2 | chr6:26838000-26866200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr6:26838400-26853400 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr6:26838800-26857600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:26839000-26850600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr6:26841400-26866200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr6:26843600-26848600 | Weak transcription | Fetal Stomach | stomach |
8 | chr6:26844400-26847000 | Weak transcription | Placenta Amnion | Placenta Amnion |
9 | chr6:26844400-26849800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr6:26844400-26849800 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
11 | chr6:26844400-26854200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr6:26844400-26854800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr6:26844400-26856000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr6:26844400-26865800 | Weak transcription | Ovary | ovary |
15 | chr6:26844400-26872000 | Weak transcription | Fetal Intestine Small | intestine |
16 | chr6:26844600-26853200 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
17 | chr6:26844600-26853800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
18 | chr6:26844600-26857600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr6:26844800-26857800 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
20 | chr6:26845000-26853400 | Weak transcription | Brain Hippocampus Middle | brain |
21 | chr6:26845000-26864200 | Weak transcription | Pancreas | Pancrea |
22 | chr6:26845200-26851600 | Weak transcription | Gastric | stomach |
23 | chr6:26845400-26853200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
24 | chr6:26846200-26849600 | Weak transcription | Spleen | Spleen |